Related Experiment Videos
Phobic anxiety and increased risk of mortality in coronary heart disease
Lana L Watkins1, James A Blumenthal, Michael A Babyak
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. watki017@mc.duke.edu
Insights
Phobic anxiety increases cardiac mortality risk in women with coronary heart disease (CHD). This study found that reduced heart rate variability (HRV) did not mediate this risk in female patients.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Phobic anxiety may increase cardiac mortality risk in medically healthy individuals.
- Established coronary heart disease (CHD) patients may also be at risk.
- The role of heart rate variability (HRV) in this association is not fully understood.
Purpose of the Study:
- To evaluate the association between phobic anxiety and cardiac mortality risk in patients with established CHD.
- To investigate whether reduced HRV mediates this potential risk.
- To examine gender differences in this association.
Main Methods:
- Prospective cohort study of 947 CHD patients.
- Baseline assessment included heart rate recordings for HRV and the Crown-Crisp phobic anxiety scale.
- Fatal cardiac events were tracked for an average of 3 years.
Main Results:
- Female CHD patients reported higher phobic anxiety levels than males.
- Phobic anxiety showed a significant interaction with gender in predicting cardiac mortality and sudden cardiac death.
- In women, phobic anxiety was associated with a 1.6-fold increased risk of cardiac mortality and a 2.0-fold increased risk of sudden cardiac death.
- Phobic anxiety was not associated with increased mortality risk in men.
- Reduced HRV was weakly associated with phobic anxiety in women but did not mediate the mortality risk.
Conclusions:
- Phobic anxiety is prevalent in women with CHD and may be a significant risk factor for cardiac mortality.
- Reduced resting HRV does not appear to mediate the increased cardiac mortality risk associated with phobic anxiety in women with CHD.
Objectives:
To evaluate whether phobic anxiety is associated with increased risk of cardiac mortality in individuals with established coronary heart disease (CHD) and to examine the role of reduced heart rate variability (HRV) in mediating this risk. Previous findings suggest that phobic anxiety may pose increased risk of cardiac mortality in medically healthy cohorts.
Methods:
We performed a prospective cohort study in 947 CHD patients recruited during hospitalization for coronary angiography. At baseline, supine recordings of heart rate for HRV were collected, and participants completed the Crown-Crisp phobic anxiety scale. Fatal cardiac events were identified over an average period of 3 years.
Results:
Female CHD patients reported significantly elevated levels of phobic anxiety when compared with male patients (p < .001), and survival analysis showed an interaction between gender and phobic anxiety in the prediction of cardiac mortality (p = .058) and sudden cardiac death (p = .03). In women, phobic anxiety was associated with a 1.6-fold increased risk of cardiac mortality (hazard ratio, 1.56; 95% confidence interval, 1.15-2.11; p = .004) and a 2.0-fold increased risk of sudden cardiac death (hazard ratio, 2.02; 95% confidence interval, 1.16-3.52; p = .01) and was unassociated with increased mortality risk in men (p = .56). Phobic anxiety was weakly associated with reduced high-frequency HRV in female patients (r = -.14, p = .02), but reduced HRV did not alter the association between phobic anxiety on mortality.
Conclusions:
Phobic anxiety levels are high in women with CHD and may be a risk factor for cardiac-related mortality in women diagnosed with CHD. Reduced HRV measured during rest does not seem to mediate phobic anxiety-related risk.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Panic Disorder
Coronary Artery Disease I: Introduction
Preparedness and Phobias
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Coronary Artery Disease IV: Preventive Measures